Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Altimeter, DST Global, Craft Ventures and Coatue, as investors in the transaction. Glean, an AI enterprise search startup,...
Glean’s $260 Million Series E Financing Round
AllianceBernstein’s Launch of AB CarVal Credit Opportunities Fund
Dechert advised AllianceBernstein on the transaction. AllianceBernstein L.P. (“AB”), a leading global investment management firm, completed the launch of their AB CarVal Credit Opportunities Fund (ABAYX),...
Finkargo’s $20 Million Equity Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Finkargo in the deal. Finkargo, a Latin American-based fintech, announced raising $20 million in equity financing led by...
Tohopekaliga Water Authority’s $292 Million Federal Loan to Expand Water Services in Central Florida
Holland & Knight assisted the Tohopekaliga Water Authority (Toho) on the matter. Tohopekaliga Water Authority (Toho) secured up to $292.755 million Water Infrastructure Finance and Innovation...
Warburg Pincus’ Inaugural $4 Billion Capital Solutions Fund
Kirkland & Ellis represented Warburg Pincus in the transaction. Warburg Pincus, a leading global growth investor, announced the formation of its inaugural capital solutions fund, Warburg...
Palomar Health’s Data Privacy Class Action
Holland & Knight successfully represented Palomar Health in the case. Palomar Health secured a dismissal of the class action lawsuit involving its alleged misuse of online...
Neo Medical SA’s Series B and $68 Million Equity Investment
Wilson Sonsini Goodrich & Rosati advised Neo Medical on U.S. aspects of the financing. Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery,...
Falfurrias Management Partners’ Investment in Snak King
K&L Gates advised Falfurrias, while Sheppard Mullin advised Snak King in the transaction. Snak King, one of the largest producers of co-manufactured and private-label salty snacks...
Organon’s Acquisition of Dermavant from Roivant
Freshfields advised Roivant in sale of Dermavant to Organon. Organon & Co. has announced the acquisition of Dermavant Sciences Ltd., a subsidiary of Roivant Sciences Ltd.,...
BioCardia’s $7.2 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised BioCardia, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. BioCardia, Inc. (Nasdaq: BCDA) completed its $7.2 million...
Uranium Royalty Corp’s Renewal of its At-the-Market Equity Program for US$39m
Gowling WLG advised the Agents. Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) (the “Company”) has renewed its at-the-market equity program (“ATM Program”), enabling the distribution of...
Zenas BioPharma’s $225 Million IPO
Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...